未登录 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
Nivolumab plus chemotherapy or ipilimumab in gastroesophageal cancer: exploratory biomarker analyses of a randomized phase 3 trial 纳武利尤单抗联合化疗或伊匹木单抗治疗胃癌和食管癌：一项随机III期试验的探索性生物标志物分析 Shitara, Kohei; Janjigian, Yelena Y.; Ajani, Jaffer; Moehler, Markus; Yao, Jin; Wang, Xuya; Chhibber, Aparna; Pandya, Dimple; Shen, Lin; Garrido, Marcelo; Gallardo, Carlos; Wyrwicz, Lucjan; Yamaguchi, Kensei; Skoczylas, Tomasz; Bragagnoli, Arinilda; Liu, Tianshu; Schenker, Michael; Yanez, Patricio; Kowalyszyn, Ruben; Karamouzis, Michalis; Zander, Thomas; Feeney, Kynan; Elimova, Elena; Doshi, Parul; Li, Mingshun; Lei, Ming 分享 收藏
Collagen turnover biomarkers to predict outcome of patients with biliary cancer 胶原蛋白周转生物标志物预测胆道癌患者预后的研究 Kaps, Leonard; Genc, Muhammed A.; Moehler, Markus; Grabbe, Stephan; Schattenberg, Joern M.; Schuppan, Detlef; Pedersen, Rasmus Sund; Karsdal, Morten A.; Mildenberger, Philipp; Maderer, Annett; Willumsen, Nicholas 分享 收藏
Prevalence of current suicidal thoughts and lifetime suicide attempts in individuals with cancer and other chronic diseases in Germany: Evidence for differential associations from a representative community cohort Schwinn, Tamara; Paul, Roman H.; Hirschmiller, Judith; Braehler, Elmar; Wiltink, Joerg; Zwerenz, Ruediger; O'Connor, Rory C.; Wild, Philipp S.; Muenzel, Thomas; Koenig, Jochem; Geschke, Katharina; Moehler, Markus; Konstantinides, Stavros; Justenhoven, Christina; Lackner, Karl J.; Pfeiffer, Norbert; Beutel, Manfred E.; Ernst, Mareike 分享 收藏
Immune checkpoint inhibitors in advanced gastroesophageal adenocarcinoma: a series of patient-level meta-analyses in different programmed death-ligand 1 subgroups 晚期胃食管腺癌的免疫检查点抑制剂: 不同程序性死亡配体1亚组患者水平的一系列荟萃分析 Leone, A. G.; Mai, A. S.; Fong, K. Y.; Yap, D. W. T.; Kato, K.; Smyth, E.; Moehler, M.; Seong, J. T. C.; Sundar, R.; Zhao, J. J.; Pietrantonio, F. 分享 收藏
Tislelizumab (TIS) plus chemotherapy (CT) vs placebo (PBO) + CT in HER2-negative advanced or metastatic gastric or gastro-oesophageal junction adenocarcinoma (GC/GEJC): RATIONALE-305 study minimum 3-year survival follow-up 替雷利珠单抗（TIS）联合化疗（CT）对比安慰剂（PBO）联合化疗（CT）治疗HER2阴性晚期或转移性胃或胃食管结合部腺癌（GC/GEJC）：RATIONALE-305研究至少3年生存随访 Cruz-Correa, M.; Oh, D-Y.; Kato, K.; Tabernero, J.; Bai, Y.; Shi, J.; Lee, K-W.; Hirano, H.; Spigel, D. R.; Wyrwicz, L. S.; Pazo Cid, R. A.; Cubillo Gracian, A.; Li, L.; Xu, Y.; Sheng, T.; Yang, S.; Xu, R-H.; Moehler, M. 分享 收藏
Plain language summary of the FOENIX-CCA2 study: futibatinib for people with advanced bile duct cancer FOENIX-CCA2研究的简明语言摘要: futibatinib用于晚期胆管癌患者 Goyal, Lipika; Meric-Bernstam, Funda; Hollebecque, Antoine; Valle, Juan W.; Morizane, Chigusa; Karasic, Thomas B.; Abrams, Thomas A.; Furuse, Junji; Kelley, Robin Katie; Cassier, Philippe A.; Klumpen, Heinz-Josef; Chang, Heung-Moon; Chen, Li-Tzong; Tabernero, Josep; Oh, Do-Youn; Mahipal, Amit; Moehler, Markus; Komatsu, Yoshito; Ahn, Daniel H.; Epstein, Robert S.; Halim, Abdel-Baset; Wacheck, Volker; He, Yaohua; Liu, Mei; Benhadji, Karim A.; Bridgewater, John A. 分享 收藏
Bintrafusp alfa and chemotherapy as first-line treatment in biliary tract cancer: A randomized phase 2/3 trial Oh, Do-Youn; Ikeda, Masafumi; Lee, Choong-kun; Rojas, Carlos; Hsu, Chih-Hung; Kim, Jin Won; Shen, Lin; Furuse, Junji; Park, Joon Oh; Borad, Mitesh; de Braud, Filippo; Bridgewater, John; Lee, Sunyoung S.; Moehler, Markus; Audhuy, Francois; Osada, Motonobu; Sato, Masashi; Yoo, Changhoon 分享 收藏
Nivolumab (NIVO) plus chemotherapy (chemo) vs chemo as first-line (1L) treatment for advanced gastric cancer/ gastroesophageal junction cancer/esophageal adenocarcinoma (GC/GEJC/EAC): Additional analyses from 4year (y) follow-up (FU) of CheckMate 649 Wyrwicz, L. S.; Shitara, K.; Moehler, M.; Ajani, J. A.; Shen, L.; Garrido, M.; Gallardo Araneda, C. E.; Yamaguchi, K.; Cleary, J.; Elimova, E.; Bruges Maya, R.; Karamouzis, M. V.; Skoczylas, T.; Bragagnoli, A. C.; Liu, T.; Tehfe, M.; Feeney, K.; Wang, R.; Zhang, J.; Janjigian, Y. Y. 分享 收藏
European clinical practice guidelines for the definition, diagnosis, and treatment of oligometastatic esophagogastric cancer (OMEC-4) 欧洲寡转移食管胃癌的定义、诊断和治疗临床实践指南 (OMEC-4) Kroese, Tiuri E.; Bronzwaer, Sebastiaan; van Rossum, Peter S. N.; Schoppman, Sebastian F.; Deseyne, Pieter R. A. J.; van Cutsem, Eric; Haustermans, Karin; Nafteux, Philippe; Thomas, Melissa; Obermannova, Radka; Mortensen, Hanna R.; Nordsmark, Marianne; Pfeiffer, Per; Elme, Anneli; Adenis, Antoine; Piessen, Guillaume; Bruns, Christiane J.; Lordick, Florian; Gockel, Ines; Moehler, Markus; Gani, Cihan; Liakakos, Theodore; Reynolds, John, V; Morganti, Alessio G.; Rosati, Riccardo; Castoro, Carlo; Cellini, Francesco; D'Ugo, Domenico; Roviello, Franco; Bencivenga, Maria; de Manzoni, Giovanni; Henegouwen, Mark I. van Berge; Hulshoff, Maarten C. C. M.; van Dieren, Jolanda; Vollebergh, Marieke; van Sandick, Johanna W.; Jeene, Paul; Muijs, Christel; Slingerland, Marije; Voncken, Francine E. M.; Hartgrink, Henk; Creemers, Geert-Jan; van der Sangen, Maurice J. C.; Nieuwenhuijzen, Grard A. P.; Berbee, Maaike; Verheij, Marcel; Wijnhoven, Bas; V. Beerepoot, Laurens; Mohammad, Nadia Haj; Mook, Stella; Ruurda, Jelle P.; Kolodziejczyk, Piotr; Polkowski, Wojciech P.; Wyrwicz, Lucjan; Alsina, Maria; Tabernero, Josep; Pera, Manuel; Kanonnikoff, Tania F.; Cervantes, Andres; Nilsson, Magnus; Monig, Stefan; Wagner, Anna D.; Guckenberger, Matthias; Griffiths, Ewen A.; Smyth, Elizabeth; Hanna, George B.; Markar, Sheraz; Chaudry, M. Asif; Hawkins, Maria A.; Cheong, Edward; van Laarhoven, Hanneke W. M.; van Hillegersberg, Richard 分享 收藏
Tislelizumab (TIS) plus chemotherapy (CT) vs placebo (PBO) plus CT in HER2-negative advanced or metastatic gastric or gastro-esophageal junction adenocarcinoma (GC/GEJC): PDL1 biomarker analysis from RATIONALE-305 Tislelizumab (TIS) 加化疗 (CT) 与安慰剂 (PBO) 加CT治疗HER2-negative晚期或转移性胃或胃食管交界处腺癌 (GC/GEJC): PDL1生物标志物分析的原理-305 Moehler, M.; Oh, D-Y.; Kato, K.; Tabernero, J.; Cruz-Correa, M.; Wyrwicz, L. S.; Pazo Cid, R. A.; Cubillo, A.; Evesque, L.; Fornaro, L.; Dotan, E.; Morgan, C.; Li, L.; Xu, Y.; Sheng, T.; Yang, S.; Hu, H.; Xu, R-H. 分享 收藏
Multicenter analysis on the value of standard (chemo)radiotherapy in elderly patients with locally advanced adenocarcinoma of the esophagus or gastroesophageal junction Bostel, Tilman; Nikolaidou, Eirini; Wollschlaeger, Daniel; Mayer, Arnulf; Kaufmann, Justus; Hopprich, Anne; Ruehle, Alexander; Grosu, Anca-Ligia; Debus, Jurgen; Fottner, Christian; Moehler, Markus; Grimminger, Peter; Schmidberger, Heinz; Nicolay, Nils Henrik 分享 收藏
Pathological complete response (pCR) to durvalumab plus 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in resectable gastric and gastroesophageal junction cancer (GC/GEJC): Interim results of the global, phase III MATTERHORN study durvalumab联合5-氟尿嘧啶、亚叶酸、奥沙利铂和多西他赛 (FLOT) 治疗可切除胃癌和胃食管交界癌 (GC/GEJC) 的病理完全缓解 (pCR): 全球III期马特洪峰研究的中期结果 Oh, D-Y.; Janjigian, Y. Y.; Al-Batran, S-E.; Wainberg, Z. A.; van Cutsem, E.; Molena, D.; Muro, K.; Hyung, W. J.; Wyrwicz, L. S.; Omori, T.; Moehler, M.; Garrido, M.; Cunha Sousa Oliveira, S.; Liberman, M.; Castro Oliden, V.; Bilici, M.; Kurland, J.; Xynos, I.; Mann, H.; Tabernero, J. 分享 收藏
Tislelizumab (TIS) plus chemotherapy (Chemo) vs placebo (PBO) plus chemo as first-line (1L) treatment of advanced gastric or gastroesophageal junction adenocarcinoma (GC/GEJC): Final analysis results of the RATIONALE-305 study Xu, R-H.; Oh, D-Y.; Kato, K.; Arkenau, H-T.; Tabernero, J.; Cruz-Correa, M.; Zimina, A. V.; Bai, Y.; Shi, J.; Lee, K-W.; Hirano, H.; Spigel, D. R.; Wyrwicz, L. S.; Pazo Cid, R. A.; Li, L.; Xu, Y.; McHenry, M. B.; Yang, S.; Moehler, M. 分享 收藏
Pathological complete response (pCR) to durvalumab plus 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) in resectable gastric and gastroesophageal junction cancer (GC/GEJC): Interim results of the global, phase III MATTERHORN study Janjigian, Y. Y.; Al-Batran, S-E.; Wainberg, Z. A.; Van Cutsem, E.; Molena, D.; Muro, K.; Hyung, W. J.; Wyrwicz, L. S.; Oh, D. Y.; Omori, T.; Moehler, M.; Garrido, M.; Oliveira, S. Cunha Sousa; Liberman, M.; Oliden, V. Castro; Bilici, M.; Kurland, J. F.; Xynos, I.; Mann, H.; Tabernero, J. 分享 收藏
Phase Ib results of bemarituzumab (BEMA)+mfolfox6+nivolumab (NIVO) for advanced gastric/ gastroesophageal junction cancer (G/GEJC): Fortitude-102 part 1 Wainberg, Z. A.; Yamaguchi, K.; Ajani, J. A.; Chao, J.; Moehler, M.; Kang, Y-K.; Van Cutsem, E.; Yen, P.; Motii, Y.; Zhou, D.; Dos Santos, T. Murias; Shitara, K. 分享 收藏
.png){kind=icon}
.png){kind=icon}
.png)
BMC Cancer.png)
OAAI
.png){kind=icon}
分享.png){kind=icon}
收藏